Integral Diagnostics Ltd (IDX)

Currency in AUD
2.19
-0.01(-0.45%)
Closed·

IDX Earnings

Latest Release
Feb 23, 2026
EPS / Forecast
0.02 / 5.40
Revenue / Forecast
393.48M / 249.71M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2025/120.020/5.40393.48M/249.71M-99.63%+57.57%Free Sign Up
2025/060.010/0.061374.34M/247.07M-83.58%+51.51%Free Sign Up
2024/120.000/0.071252.87M/237.38M-100%+6.53%Free Sign Up
2022/120.070/6.62215.70M/175.92M-98.94%+22.61%Free Sign Up
2022/060.020/0.090179.40M/177.26M-77.78%+1.21%Free Sign Up
2021/120.050/0.110181.50M/171.00M-54.55%+6.14%Free Sign Up
2021/060.060/0.080178.90M/170.21M-25%+5.11%Free Sign Up
2020/120.100/0.110171.70M/164.14M-9.09%+4.61%Free Sign Up
2020/060.060/0.080143.10M/146.95M-25%-2.62%Free Sign Up
2019/120.060/8.53132.50M/115.90M-99.3%+14.32%Free Sign Up

All numbers in AUD

Integral Diagnostics Ltd Earnings Call Summary for H1/2026

  • Revenue jumped 55.6% to 393.5M AUD in H1 FY2026, driven by Capital Diagnostics merger and organic growth in Australia and New Zealand.
  • Operating EBITDA surged 75.6% to 81.1M AUD with margins expanding 230 bps to 20.6%; operating NPAT increased 154.6% to 22.3M AUD.
  • Interim dividend raised 32% to 0.033 AUD per share; net debt-to-EBITDA improved to 2.5x from 2.8x, strengthening balance sheet.
  • Company expects continued growth from MRI deregulation, teleradiology expansion (radiologist base up 33%), and government health initiatives.
  • Stock declined 2.08% to 2.4 AUD despite strong results; key risks include integration costs, labor shortages, and competitive pressures.
Last Updated: 2026-02-23, 08:40 p/m
Read Full Transcript

FAQ

What Is Integral Diagnostics Ltd's Earnings Per Share (TTM)?

The Integral Diagnostics Ltd EPS (TTM) is 0.04.

What Is Integral Diagnostics Ltd’s Revenue Forecasts For Upcoming Quarters?

Integral Diagnostics Ltd’s revenue forecast is 285.00M.

How Did Integral Diagnostics Ltd React to the Company's Latest Earnings Report?

Integral Diagnostics Ltd reported a -83.58% EPS surprise and a +51.51% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -6.22%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.